The agreement now includes distribution of Roche's Kapa Biosystems portfolio in all geographies except the US, Brazil, and Japan.
Under the terms of the deal, Color Genomics will integrate Kapa Biosystems' library construction reagents into its NGS workflow.
The certification enables the reagent maker to create optimizing products for use beyond the research market.
Kapa offers "essential components" to Roche's overall NGS solution and enables Roche to improve the workflow of its NGS platforms.
Roche said the acquisition will strengthen its next-generation sequencing product offerings.
Kapa will supply DNA library prep reagents for 10X's GemCode platform to enable a more streamlined workflow and higher quality sequencing data.
Kapa will manufacture versions of its RNA-seq kits for distribution with Roche's RNA target enrichment system.
The firm will transition from its current partnership with Anachem to a direct sales and support channel in the UK as it expands its European operations.
NEW YORK (GenomeWeb) — Kapa Biosystems said today that it has signed a three-year exclusive distribution agreement with Nippon Genetics.
The president of France's National Research Agency has resigned, according to Nature News.
A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.
In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.
The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.